A significant breakthrough in cancer research is occurring with the use of VHH fragments to re-engage mutated p53. This vital tumor inhibitor protein is frequently inactivated in many forms of malignancies, resulting https://classifylist.com/story23963072/mini-antibodies-revive-the-p53-protein-the-promising-approach-for-tumor-therapy